2021
DOI: 10.1016/j.ijcard.2020.08.083
|View full text |Cite
|
Sign up to set email alerts
|

CircRNA circHIPK3: A novel, potential therapeutic target in the treatment of angiotensin II-induced cardiac fibrosis?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 5 publications
0
1
0
Order By: Relevance
“…Overexpressed circHIPK3 strengthened TGF-β2 signaling pathway by hampering miR-152-3p so as to accelerate the process of fibrosis [ 90 ]. Liu et al along with Ni and colleagues also demonstrated that silencing circHIPK3 contributed to retard cardio fibrosis triggered by angiotensin II [ 91 , 92 ]. Ni and colleagues further discovered the miRNA sponged by circHIPK3 as miR-29b-3p in their study [ 92 ].…”
Section: The Role Of Circhipk3 In Cardiovascular Diseasementioning
confidence: 99%
“…Overexpressed circHIPK3 strengthened TGF-β2 signaling pathway by hampering miR-152-3p so as to accelerate the process of fibrosis [ 90 ]. Liu et al along with Ni and colleagues also demonstrated that silencing circHIPK3 contributed to retard cardio fibrosis triggered by angiotensin II [ 91 , 92 ]. Ni and colleagues further discovered the miRNA sponged by circHIPK3 as miR-29b-3p in their study [ 92 ].…”
Section: The Role Of Circhipk3 In Cardiovascular Diseasementioning
confidence: 99%